Parul Katoch
Senior Principal Scientist Pfizer
Dr. Parul Katoch is a Senior Principal Scientist at Pfizer, where she advances the discovery and development of ADCs and oncology therapeutics. With more than 14 years of experience in cell and molecular biology, cancer research, and assay development, she specializes in translating innovative biology into impactful drug discovery programs. Prior to Pfizer, she held scientific roles at Seagen and Oregon Health & Science University, where she led efforts in antibody target identification, biomarker discovery, liquid biopsy technologies, and cancer diagnostics. Dr. Katoch earned her PhD in Biochemistry and Molecular Biology from the University of Nebraska Medical Center and is recognized for her expertise in oncology, translational research, and ADC development.
Seminars
- Explaining development rationale for GPNMB-targeted Auristatin-S ADCs informed by the historical therapeutic index constraints observed with vedotin-based ADCs
- Outlining preclinical data showing Auristatin-S ADC preserved potency, improved tolerability and a wider therapeutic window
- Exploring opportunity to enable higher dosing and improve clinical benefit in NSCLC, esophageal cancer, head and neck cancers and melanoma
